hotspot -WSS

hotspot

author：Wikipedia 2025-08-23 06:48:19 - browse：59

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

I have one more, admittedly braggy thing to say about last week’s STAT Breakthrough Summit West in San Francisco. Of course we curated an incredible roster of influential industry leaders to speak on stage. That’s what STAT does. But just as remarkable were the health care and health tech A-Listers who just showed up as summit attendees to listen and learn from their peers — like 23AndMe’s Anne Wojcicki. Please join us in San Francisco next year, or better yet, register for our next summit in Boston, Oct. 16-17.

I’m back in Boston from San Francisco, but flying out again next week, this time to Chicago for the annual meeting of the American Society of Clinical Oncology. How can we be knocking on June, already?

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Medicare Advantage isn’t working — for anyone

WSS

Chan Zuckerberg Biohub Chicago to focus on inflammation

Why Charlie Gard's case is so disturbing to Americans

STAT Madness 2024: Meet the contenders

Analysis of telehealth claims data suggest service duplication

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Laying a path for careers in science

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

How one medical school became remarkably diverse

Virtual repurposing can help discover new uses for existing drugs

In Memoriam: Notable people who died in 2023

Pfizer is about to make a big push in cancer. Will investors listen?

Moonlake's readout produced a cash windfall. Risks remain

When women are denied an abortion, their children fare worse than peers

Anesthesiologist group: stop taking Ozempic before surgery

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Study fuels hope CAR

leisure time

Redefining sustainability for the pharmaceutical industry

Neuroscience renaissance leads to new crop of psychiatric drugs

Medicare isn't yet testing food as medicine

Medicare Advantage isn’t working — for anyone

Pfizer is about to make a big push in cancer. Will investors listen?

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

entertainment

entertainment

explore

focus